000 07911nam a22006135i 4500
001 978-3-030-02278-5
003 DE-He213
005 20210511121146.0
007 cr nn 008mamaa
008 181212s2019 gw | s |||| 0|eng d
020 _a9783030022785
_9978-3-030-02278-5
024 7 _a10.1007/978-3-030-02278-5
_2doi
050 4 _aRB45
072 7 _aMJF
_2bicssc
072 7 _aMED038000
_2bisacsh
072 7 _aMJF
_2thema
082 0 4 _a616.15
_223
245 1 4 _aThe EBMT Handbook
_h[electronic resource] :
_bHematopoietic Stem Cell Transplantation and Cellular Therapies /
_cedited by Enric Carreras, Carlo Dufour, Mohamad Mohty, Nicolaus Kröger.
250 _a7th ed. 2019.
264 1 _aCham :
_bSpringer International Publishing :
_bImprint: Springer,
_c2019.
300 _aXL, 702 p. 56 illus., 38 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aPart 1. Introduction -- 1. HSCT: Historical perspective -- 2. The EBMT: History, present and future -- 3. The role of unrelated donor registries in HSCT -- 4. The HSCT Unit -- 5. JACIE accreditation of HSCT programs -- 6. Statistical methods in HSCT and Cellular Therapies -- Part 2. Biological aspects -- 7. Biological properties of HSC: scientific basis for HSCT -- 8. Biological properties of cells other than HSC -- 9. Histocompatibility -- 10. Clinical & biological concepts for mastering Immune reconstitution after HSCT: towards practical guidelines and greater harmonization -- Part 3. Methodology and clinical aspects -- 11. Evaluation and counselling of candidates -- 12. Donor selection for adults and pediatrics -- 13. Conditioning -- 14. Bone marrow harvesting for HSCT -- 15. Mobilization and collection of HSC -- 16. Collection of HSC in children -- 17. Processing, cryopreserving, and controlling the quality of HSCs -- 18. Procurement and management of cord blood -- 19. Graft manipulation -- 20. Documentation of engraftment and chimerism after HSCT -- 21. Short and long-term controls after HSCT -- Part 4. General management of the patient -- 22. Vascular access -- 23. Transfusion support -- 24. Nutritional support -- 25. GVHD prophylaxis (immunosuppression) -- 26. Management ATG (SIRS) -- 27. Infections control and isolation procedures -- 28. General management of the patient; Specific aspects of children -- 29. Vaccinations -- 30. Psychological morbidity and support -- 31. Clinical relevant drug interactions in HSCT -- 32. Role of nursing in HSCT -- 33. Ethical issues in HSCT -- 34. Quality of life assessment after HSCT for pediatric and adults -- Part 5. HSCT complications and management -- 35. Neutropenic fever -- 36. Bacterial infections -- 37. Invasive fungal infections -- 38. Viral infections -- 39. Other life-threatening infections -- 40. Bleeding and thrombotic complications -- 41. Graft failure -- 42. Early complications of endothelial origin -- 43. Acute Graft-versus-Host Disease -- 44. Chronic Graft-versus-Host Disease -- 45. Post-transplant lymphoproliferative syndromes -- 46. Iron overload -- 47. Secondary neoplasia (other than PTLPS) -- Part 6. Specific organ complications -- 48. Ocular and oral complications -- 49. Hepatic complications -- 50. Gastrointestinal complications -- 51. Hemorrhagic cystitis and renal dysfunction -- 52. Non-infectious pulmonary complications -- 53. Neurological complications -- 54. Skin, hair and musculoskeletal complications -- 55. Cardiovascular diseases and metabolic syndrome -- 56. Endocrine disorders, fertility and sexual health -- Part 7. Prevention and management of relapse -- 57. Monitoring MRD in ALL and AML -- 58. Preventing/treating relapse with drugs -- 59. Delayed transfer of immune cells, or the art of Donor Lymphocyte Infusion -- 60. Cellular therapy with engineered T cells, efficacy and side effects -- 61. Mechanisms of Immune resistance -- 62. Regulatory Aspects of ATMP versus minimally manipulated immune cells -- Part 8. Specific modalities of HSCT and management -- 63. At-home HSCT -- 64. Umbilical cord blood transplantation in children and adults -- 65. Haploidentical HSCT -- 66. Photopheresis in adults and pediatrics -- 67. Overweight and obese patients -- 68. HSCT in elderly patients -- Part 9. Indications and results -- 69. Acute Myeloid Leukemia in adults -- 70. Acute Myeloid Leukemia in children -- 71. Acute Lymphoblastic Leukemia in adults -- 72. Acute lymphoblastic leukemia in children and adolescents -- 73. Myelodysplastic syndromes -- 74. Pediatric MDS including Refractory Cytopenia and Juvenile Myelomonocytic Leukemia -- 75. Myelodysplastic/myeloproliferative neoplasms -- 76. Myeloproliferative neoplasms -- 77. Severe aplastic anemia and PNH -- 78. Fanconi anemia and other hereditary Bone Marrow Failure syndromes -- 79. Hemoglobinopathies (Sickle Cell Disease and Thalassemia) -- 80. Multiple myeloma -- 81. Systemic light chain amyloidosis -- 82. POEMS syndrome and disease produced by other monoclonal immunoglobulins -- 83. Follicular lymphoma -- 84. Chronic lymphocytic leukemia -- 85. Diffuse large B cell lymphoma -- 86. Mantle cell lymphoma -- 87. Other T- and B-aggressive lymphomas and lymphomas associated to HIV -- 88. Classical Hodgkin’s lymphoma -- 89. Primary immunodeficiencies -- 90. Inborn error of metabolism and osteopetrosis -- 91. Autoimmune disease -- 92. Solid tumors.
506 0 _aOpen Access
520 _aThis Open Access 7th edition of the European Society for Blood and Marrow Transplantation (EBMT) handbook addresses the latest developments and innovations in hematopoietic stem cell transplantation and cellular therapy. Consisting of 93 chapters, it has been written by 175 leading experts in the field. Discussing all types of stem cell and bone marrow transplantation, including haplo-identical stem cell and cord blood transplantation, it also covers the indications for transplantation, the management of early and late complications as well as the new and rapidly evolving field of cellular therapies. This book provides an unparalleled description of current practices to enhance readers’ knowledge and practice skills.
650 0 _aHematology.
_95642
650 0 _aSurgical transplantation.
_95643
650 0 _aBlood transfusion.
_95644
650 0 _aPediatric surgery.
_95645
650 0 _aSurgical oncology.
_95646
650 1 4 _aHematology.
_0https://scigraph.springernature.com/ontologies/product-market-codes/H3307X
_95642
650 2 4 _aTransplant Surgery.
_0https://scigraph.springernature.com/ontologies/product-market-codes/H59117
_95647
650 2 4 _aBlood Transfusion Medicine.
_0https://scigraph.springernature.com/ontologies/product-market-codes/H33029
_95648
650 2 4 _aPediatric Surgery.
_0https://scigraph.springernature.com/ontologies/product-market-codes/H59079
_95649
650 2 4 _aSurgical Oncology.
_0https://scigraph.springernature.com/ontologies/product-market-codes/H59150
_95650
700 1 _aCarreras, Enric.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_95651
700 1 _aDufour, Carlo.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_95652
700 1 _aMohty, Mohamad.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_95653
700 1 _aKröger, Nicolaus.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_95654
710 2 _aSpringerLink (Online service)
_9141
776 0 8 _iPrinted edition:
_z9783030022778
776 0 8 _iPrinted edition:
_z9783030022792
856 4 0 _uhttps://doi.org/10.1007/978-3-030-02278-5
912 _aZDB-2-SME
912 _aZDB-2-SXM
912 _aZDB-2-SOB
942 _cEBK
_w1
_xAdministrator Library
_y1
_z Administrator Library
999 _c1142
_d1142
773 _tSpringer Nature Open Access eBook